Position in AMRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$100,298,691
+$29,564,709 QoQ
Shares Held
5,794,263
+1.8% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 7%
None 5%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. AMRX ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
25,417,271 | $625,519,037 | |
| 2 | VTRS |
Viatris Inc
|
29,970,094 | $475,925,092 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
527,904 | $286,034,221 | |
| 4 | ALKS |
Alkermes plc.
|
4,194,873 | $219,811,343 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,466,260 | $162,666,882 | |
| 6 | ZTS |
Zoetis Inc.
|
2,173,278 | $156,171,754 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
2,661,291 | $125,799,224 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
732,877 | $123,519,088 |
All Filings in AMRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,298,691 | 5,794,263 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $70,733,982 | 5,690,586 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $70,673,903 | 5,609,040 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $54,365,650 | 5,431,134 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $42,855,721 | 5,297,370 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $42,764,444 | 5,103,156 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $39,534,278 | 4,991,702 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $39,212,565 | 4,713,049 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $27,202,940 | 4,283,928 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $22,073,688 | 3,642,523 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $17,133,259 | 2,822,613 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $8,333,704 | 1,974,812 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,714,140 | 1,198,110 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,865,104 | 1,341,803 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,446,041 | 1,229,168 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,747,241 | 1,360,021 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,755,137 | 1,809,792 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,835,972 | 1,639,322 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,256,950 | 1,515,021 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $7,168,373 | 1,342,392 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,088,296 | 1,384,433 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $6,176,168 | 917,707 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,050,321 | 448,648 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,147,766 | 295,816 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $939,919 | 197,462 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $37,834 | 10,872 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||